Andrea Goren - INVO Old Chief Officer
Insider
Andrea Goren is Chief Officer of INVO Old
| Age | 57 |
| Phone | 978 878 9505 |
| Web | https://www.invobioscience.com |
Andrea Goren Latest Insider Activity
Tracking and analyzing the buying and selling activities of Andrea Goren against INVO Old stock is an integral part of due diligence when investing in INVO Old. Andrea Goren insider activity provides valuable insight into whether INVO Old is net buyers or sellers over its current business cycle. Note, INVO Old insiders must abide by specific rules, including filing SEC forms every time they buy or sell INVO Old'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Andrea Goren over six months ago Disposition of tradable shares by Andrea Goren of INVO Bioscience subject to Rule 16b-3 |
INVO Old Management Efficiency
The company has return on total asset (ROA) of (0.2657) % which means that it has lost $0.2657 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (143.5864) %, meaning that it created substantial loss on money invested by shareholders. INVO Old's management efficiency ratios could be used to measure how well INVO Old manages its routine affairs as well as how well it operates its assets and liabilities.INVO Old currently holds 8.68 M in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. INVO Old has a current ratio of 1.95, which is within standard range for the sector. Note, when we think about INVO Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Hillel MBA | Entera Bio | 47 | |
| II MD | Entera Bio | 71 | |
| Sharon Keys | NLS Pharmaceutics AG | N/A | |
| Wilson Wong | CLPS Inc | N/A | |
| iur LLM | NLS Pharmaceutics AG | 58 | |
| Peter Facchini | Enveric Biosciences | 61 | |
| Rui Yang | CLPS Inc | 42 | |
| Chad MBA | NLS Pharmaceutics AG | N/A | |
| Miranda MBA | Entera Bio | 48 | |
| John MD | Lixte Biotechnology Holdings | 87 | |
| Joseph Tucker | Enveric Biosciences | 56 | |
| James MD | Lixte Biotechnology Holdings | 77 | |
| Xiao Yang | CLPS Inc | 60 | |
| Ming Lin | CLPS Inc | 61 | |
| Robert Weingarten | Lixte Biotechnology Holdings | 73 | |
| Avani Kanubaddi | Enveric Biosciences | 51 | |
| Ibrahim MD | Enveric Biosciences | 55 | |
| Srustijeet Mishra | CLPS Inc | N/A | |
| Eric JD | Lixte Biotechnology Holdings | 46 | |
| MBA IV | Enveric Biosciences | 68 | |
| Rhon Galicha | CLPS Inc | N/A | |
Management Performance
| Return On Equity | -143.59 | |||
| Return On Asset | -0.27 |
INVO Old Leadership Team
Elected by the shareholders, the INVO Old's board of directors comprises two types of representatives: INVO Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INVO. The board's role is to monitor INVO Old's management team and ensure that shareholders' interests are well served. INVO Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INVO Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin MD, Medical Director | ||
| FACS FACOG, VP Integration | ||
| Bojan Mitrovic, Director US | ||
| Lori MarzilliKahler, VP Operations | ||
| Michael Campbell, COO Development | ||
| Terah Krigsvold, Controller | ||
| Chris Myer, Sr Americas | ||
| Steven Shum, CEO Director | ||
| Andrea Goren, Chief Officer | ||
| Robert Bowdring, Treasurer Secretary |
INVO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is INVO Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -143.59 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (1.23) % | |||
| Operating Margin | (1.04) % | |||
| Current Valuation | 15.19 M | |||
| Shares Outstanding | 3.91 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Number Of Shares Shorted | 1.95 K | |||
| Price To Book | 5.97 X |
Pair Trading with INVO Old
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if INVO Old position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Old will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Quanta Services could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Quanta Services when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Quanta Services - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Quanta Services to buy it.
The correlation of Quanta Services is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Quanta Services moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Quanta Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Quanta Services can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in INVO Stock
If you are still planning to invest in INVO Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Old's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |